Biotech Stocks
17 stocks · Healthcare sector · flow as of Oct 20, 2026 close
Biotech stocks: what the data says
As of the Oct 20, 2026 close, NextPick's Biotech basket shows neutral (flow score -6). That is the 55th-weakest money flow of 110 industry baskets tracked. The basket was up 3.4% on the day and up 5.2% over five sessions.
The basket holds 17 Biotech stocks in the Healthcare sector. The largest by market cap are VRTX, MRNA and REGN. The median member is down 4.6% over the past month. Best one-month returns: MRNA (+40.0%), UTHR (+12.3%) and BIIB (+11.0%). Weakest: TVTX (−16.8%), BMRN (−11.9%) and ROIV (−10.4%). On the latest close, 3 members showed inflow and 7 showed outflow.
5 Biotech companies report earnings in the next 30 days: BMRN (Oct 26), BIIB (Oct 28), REGN (Oct 30), NBIX (Nov 2) and VRTX (Nov 2).
Biotech stocks list
| Stock | Market cap | Close | 1D | 1M | 3M | Money flow |
|---|---|---|---|---|---|---|
| VRTX stockVertex Pharmaceuticals IncorporVRTX earnings | $126.6B | $514.65 | +2.53% | +0.77% | +8.90% | neutral |
| MRNA stockModerna, Inc. | $87.0B | $242.08 | +6.69% | +39.98% | +316.88% | inflow |
| REGN stockRegeneron Pharmaceuticals, Inc.REGN earnings | $81.4B | $807.48 | +3.25% | +1.17% | +24.00% | neutral |
| BIIB stockBiogen Inc.BIIB earnings | $34.4B | $243.10 | +4.12% | +10.97% | +22.94% | neutral |
| ALNY stockAlnylam Pharmaceuticals, Inc. | $31.0B | $230.71 | -1.11% | -5.57% | -13.59% | neutral |
| INCY stockIncyte Corporation | $22.9B | $116.61 | +2.97% | -6.45% | +0.71% | strong outflow |
| UTHR stockUnited Therapeutics Corporation | $22.9B | $553.88 | +1.98% | +12.33% | +5.09% | neutral |
| BNTX stockBioNTech SE | $22.0B | $91.17 | +2.20% | -6.97% | -0.72% | neutral |
| NBIX stockNeurocrine Biosciences, Inc.NBIX earnings | $13.8B | $142.00 | +3.66% | -1.36% | -17.77% | neutral |
| SMMT stockSummit Therapeutics Inc.SMMT earnings | $12.4B | $16.09 | +3.34% | -4.79% | +9.16% | weak inflow |
| BMRN stockBioMarin Pharmaceutical Inc.BMRN earnings | $10.6B | $56.44 | +3.24% | -11.90% | -3.36% | weak outflow |
| TGTX stockTG Therapeutics, Inc. | $8.6B | $54.53 | +2.31% | -4.60% | +3.51% | outflow |
| SRPT stockSarepta Therapeutics, Inc. | $1.8B | $19.17 | +8.12% | -4.82% | +21.18% | weak outflow |
| ROIV stock | — | $34.92 | +0.63% | -10.44% | +0.03% | outflow |
| RVMD stock | — | $196.55 | +7.91% | +1.97% | +7.39% | weak inflow |
| TVTX stock | — | $52.30 | +3.58% | -16.80% | -7.04% | outflow |
| VCYT stock | — | $44.79 | +2.26% | +7.88% | -22.79% | weak outflow |
Biotech money flow, last 10 sessions
| Session | Flow score | Signal | Basket 1D |
|---|---|---|---|
| Oct 20, 2026 | -6 | neutral | +3.39% |
| Oct 19, 2026 | -20 | weak outflow | +1.60% |
| Oct 16, 2026 | -8 | neutral | -2.88% |
| Oct 15, 2026 | -9 | neutral | +1.80% |
| Oct 14, 2026 | -19 | weak outflow | +1.36% |
| Oct 13, 2026 | -21 | weak outflow | -2.85% |
| Oct 12, 2026 | -25 | weak outflow | -0.84% |
| Oct 9, 2026 | -24 | weak outflow | +2.66% |
| Oct 8, 2026 | -14 | weak outflow | -1.15% |
| Oct 7, 2026 | -26 | weak outflow | +0.00% |
Upcoming Biotech earnings
- BMRN earningsOct 26, 2026 · after market close
- BIIB earningsOct 28, 2026
- REGN earningsOct 30, 2026
- NBIX earningsNov 2, 2026
- VRTX earningsNov 2, 2026
Biotech stocks: key questions
What are the biggest Biotech stocks?
By market cap, the largest Biotech stocks NextPick tracks are Vertex Pharmaceuticals Incorpor (VRTX), Moderna, Inc. (MRNA), Regeneron Pharmaceuticals, Inc. (REGN), Biogen Inc. (BIIB) and Alnylam Pharmaceuticals, Inc. (ALNY).
Is money flowing into Biotech stocks?
On the Oct 20, 2026 close, flow is roughly balanced: the basket reads neutral with a flow score of -6, up 3.4% on the day.
Which Biotech stocks performed best this month?
Over the past 21 sessions the leaders are MRNA (+40.0%), UTHR (+12.3%) and BIIB (+11.0%).
When do Biotech stocks report earnings?
BMRN reports next, on Oct 26, 2026 after market close. 5 members report within 30 days.
Baskets and money-flow scores are NextPick's own sector-flow model built from daily price and volume data; they describe past trading and are not investment advice.